<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Research Article" dtd-version="1.0"><front><journal-meta><journal-id journal-id-type="pmc">iarms</journal-id><journal-id journal-id-type="pubmed">IARMS</journal-id><journal-id journal-id-type="publisher">IARMS</journal-id><issn>2709-3255</issn></journal-meta><article-meta><article-id pub-id-type="doi">https://doi.org/10.47310/iarms.2021.v02i01.008</article-id><title-group><article-title>Evaluation of Immunohistochemical Expression of Cyclin D1 (Bcl-1) and Ki-67 antigen (MIB-1) in Cutaneous Basal Cell Carcinoma and Adjacent Epidermis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><given-names>Vladimír</given-names><surname>Bartoš</surname></name></contrib><xref ref-type="aff" rid="aff-a" /></contrib-group><aff-id id="aff-a">MD, PhD, Master of Public Health, Martin´s Biopsy Center, Prieložtek, Martin, Slovakia</aff-id><abstract>Background: The Ki-67 antigen and the D-type cyclins play a&amp;nbsp;key role in the cell cycle regulation. Objective: The goal of this study was to evaluate an immunohistochemical expression status of Cyclin D1 and Ki-67 in basal cell carcinoma (BCC) of the skin and to find out whether there is a correlation between them. Material and Methods: The study included biopsy specimens from 29 BCCs, which were immunohistochemically stained for Cyclin D1 and Ki-67. The cases were graded on a semiquantitative scale based on the average proportion of immunoreactive cells: 0 (&amp;lt;1%), 1+ (1-10%), 2+ (11-50%) and 3+ (&amp;gt;50%). Results:&amp;nbsp;All BCCs were positive for both proteins. As for Cyclin D1, the grades 1+, 2+ and 3+ were found in 4 cases (13.8%), 18 cases (62.1%) and 7 cases (24.1%). As for Ki-67, the grades 1+, 2+ and 3+ were found in 1 case (3.4%), 18 cases (62.1%) and 10 cases (34.5%). In adjacent epidermis, all cases exhibited a&amp;nbsp;mild degree of Cyclin D1 and Ki-67 immunoreactivity. Comparing both markers, there were 22 BCCs (75.9%) showing the same semiquantitative grade of Ki-67 and Cyclin D1 expression and 7 BCCs (24.1%), in which Ki-67 grade was one degree higher than Cyclin D1 grade. Conclusion: All BCCs expressed Cyclin D1 and Ki-67 that were more pronounced in tumor tissue than in adjacent normal epidermis. This indicates, both markers play a&amp;nbsp;role in the carcinogenesis of cutaneous BCC. The expression of Cyclin D1 appeared to have a positive correlation with Ki-67 expression, suggesting the production of Cyclin D1 protein is directly related to cell proliferation.</abstract></article-meta></front><body /><back /></article>